USP13 Overexpression in BMSCs Enhances Anti-Apoptotic Ability and Guards Against Methylprednisolone-Induced Osteonecrosis in Rats

Yixin Jiang,Xiaoli Fan,Yaling Yu,Hongfan Ge,Chengyin Liu,Yanyan Zhang,Lingyun Yu,Wen Yin,Zhenlei Zhou
DOI: https://doi.org/10.1093/stmcls/sxae069
IF: 5.845
2024-10-27
Stem Cells
Abstract:Methylprednisolone (MPS) use is linked to increased cases of osteonecrosis of the femoral head (ONFH). Bone marrow mesenchymal stem cells (BMSCs) have shown potential for treating MPS-induced ONFH, but their effectiveness is limited by high apoptosis rates post-transplantation. We developed a pre-treatment strategy for BMSCs to improve their viability. In a rat model of MPS-induced ONFH, we evaluated the effects of USP13 overexpression in BMSCs through micro-CT, HE staining, and TUNEL staining. USP13-overexpressing BMSCs significantly reduced ONFH severity compared to plain BMSCs and direct lentivirus injection. USP13 also protected BMSCs from MPS-induced apoptosis by modulating PTEN and reducing AKT phosphorylation. This led to decreased expression of apoptotic genes and proteins in USP13-overexpressing BMSCs. Our findings highlight USP13 as a promising target for enhancing BMSC survival and efficacy in treating MPS-induced ONFH.
oncology,cell biology,hematology,biotechnology & applied microbiology,cell & tissue engineering
What problem does this paper attempt to address?